Medigus Ltd. (MDGS) Financials

Stock symbol MDGS is outdated, potentially delisted? Maybe it is available on other exchange?

MDGS Assets vs Liabilities

Date	Assets	Liabilities
June 30, 2023	85.7 million	41.2 million
March 31, 2023	97.7 million	43.0 million
Dec. 31, 2022	97.7 million	43.0 million
Sept. 30, 2022	?	?

MDGS Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
June 30, 2023	-4.1 million	235000
March 31, 2023	-4.1 million	78000
Dec. 31, 2022	?	?
Sept. 30, 2022	-1.9 million	78000

MDGS Net Income

No data available :(

MDGS Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
June 30, 2023	14.6 million	-	612000
March 31, 2023	25.1 million	-	-
Dec. 31, 2022	25.1 million	-	643000
Sept. 30, 2022	-	-	-

MDGS Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
June 30, 2023	1.6 million
March 31, 2023	1.6 million
Dec. 31, 2022	24.6 million
Sept. 30, 2022	1.6 million

MDGS Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
June 30, 2023	1.7 million	2.6 million	4.1 million	934000
March 31, 2023	55865	2.9 million	4.3 million	947000
Dec. 31, 2022	10500	-	-	-
Sept. 30, 2022	27000	1.4 million	4.3 million	947000

MDGS Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
June 30, 2023	53.4 million	45.2 million
March 31, 2023	58.3 million	49.9 million
Dec. 31, 2022	-	-
Sept. 30, 2022	28.4 million	24.3 million

MDGS

Price: $2.36

52 week price:

2.18

7.17

Earnings Per Share: -8.70 USD

P/E Ratio: -0.35

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Country: Israel

Volume: 9158

Ebitda: -7.0 million

Market Capitalization: 4.6 million

Links:

MDGS on Yahoo Finance